ABT 702

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 2289

CAS [214697-26-4]

MF C22H19BrN6O
MW 463.33

  • Purity: 99%
  • Soluble in 0.1N HCl(aq) and DMSO

ABT 702


The first, non-nucleoside adenosine kinase (ADK) inhibitor (IC50 value 2 nM and 50 nM in cytosolic and intact cell assays, respectively). ABT702 is orally active to reduce pain and inflammation in animal models, yet found to be clastogenic in an in vitro Chinese Hamster micronucleus assay.

KEYWORDS: ABT 702 | supplier | ADK inhibitor | ABT702 | CAS [214697-26-4] | ATP | ADK | pain | inflammation | clastogenic | mutagenesis

Size Unit Price Stock
5 mg €120.00 In Stock
25 mg €420.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €180.00 In Stock
2 x 25 mg €680.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...